Clinical Trials at Montefiore Medical Center
As of September 2026, 152 paid clinical trials are recruiting at Montefiore Medical Center in The Bronx, New York. Active studies at this site cover conditions such as Breast Cancer, Acute Myeloid Leukemia and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
152 clinical trials at Montefiore Medical Center
·Clear filters·A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Patient Retrospective Outcomes (PRO)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
J-Valve Transfemoral Pivotal Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Common conditions studied in The Bronx
- Breast Cancer (13 active studies)
- Acute Myeloid Leukemia (12 active studies)
- Heart Failure (8 active studies)
- Asthma (7 active studies)
- Cardiovascular Diseases (7 active studies)
- Non-Small Cell Lung Cancer (7 active studies)
Leading research sponsors in The Bronx
- Montefiore Medical Center
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Albert Einstein College of Medicine
Frequently asked questions
How many paid clinical trials are currently recruiting in The Bronx?
There are approximately 558 recruiting clinical trials in The Bronx, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in The Bronx pay participants?
Most recruiting trials in The Bronx compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in The Bronx?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in The Bronx?
The most common conditions under active study in The Bronx include Breast Cancer (13), Acute Myeloid Leukemia (12), Heart Failure (8), Asthma (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in The Bronx?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in The Bronx on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in The Bronx?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in The Bronx?
Recruiting research sites in The Bronx include Montefiore Medical Center, Montefiore Medical Center - Moses Campus, Montefiore Medical Center-Einstein Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in The Bronx right now?
The largest active categories in The Bronx are Cancer & tumors (183), Cardiovascular (40), Neurology & pain (26). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.